Close
Biotechgate
| |

Home Page

Kawasaki City, Japan Publishes the February 2019 Issue of Kawasaki SkyFront i-Newsletter
By: PR Newswire Association LLC. - 12 Feb 2019Back to overview list

KAWASAKI CITY, Japan, Feb. 12, 2019 /PRNewswire/ --

The February 2019 issue of Kawasaki SkyFront i-Newsletter includes a video interview with Haruhiro Okuda, Director General, National Institute of Health Sciences, on the activities of the National Institute of Health Sciences; summary of news and events; and highlights of research being conducted by scientists affiliated with Kawasaki INnovation Gateway at SKYFRONT (KING SKYFRONT)—the City's flagship science and technology innovation hub focused on the life sciences and environment.

February 2019 issue of Kawasaki SkyFront iNewsletter
http://inewsletter-king-skyfront.jp/en/

The KING SKYFRONT was launched by Kawasaki City in 2013 as a base for scholars, industrialists and government administrators to work together to devise real life solutions to global issues in the life sciences and environment.

KING SKYFRONT is a 40 hectare area located in the Tonomachi area of the Keihin Industrial Region that spans Tokyo and Kanagawa Prefecture and Tokyo International Airport (Haneda Airport) and an important initiative in establishing the Tonomachi area of Kawasaki City as Asia's Silicon Valley.

Contents of the 14th issue of Kawasaki SkyFront i-Newsletter

http://inewsletter-king-skyfront.jp/en/

-----

Video Feature

Haruhiro Okuda, Ph.D.
Director General, National Institute of Health Sciences
http://inewsletter-king-skyfront.jp/en/video_feature/vol-14-feature01/

The National Institute of Health Sciences or "Kokuritsueiken" was established in 1874. It has the longest history out of all national research institutes. In early Meiji era, when the introduction of western medicine became widespread, many bad drugs came into Japan. Therefore, the government of the time established the "Tokyo Medicines Control Laboratory" to chemically analyze and examine medicines with advice from Anton Johannes Cornelis Geerts, a Dutch pharmacologist who brought in from overseas. This is the origin of our institute.

-----

Research Highlights

Replicating Parkinson's disease brains in the laboratory

Stem cell technology finds its application in elucidating Parkinson's disease using patient-derived cells
http://inewsletter-king-skyfront.jp/en/research_highlights/vol-14-research02/

Mapping brain function of monkeys

A novel technology has made it easier to visualize patterns in the brains of naturally behaving non-human primates
http://inewsletter-king-skyfront.jp/en/research_highlights/vol-14-research01/

------

News and Events

Feature article of "In-body hospitals" which is the core theme of iCONM* / COINS was published in Nature.
http://inewsletter-king-skyfront.jp/en/news/20181115/

GE Healthcare Japan and Daiwa House Industry Collaborate at the Tonomachi Open Innovation Base King SkyFront "District A" to provide a platform to accelerate the practical application of regenerative medicine
http://inewsletter-king-skyfront.jp/en/news/20180926/

Kawasaki City signs a memorandum of mutual cooperation on life sciences for the first time as a municipality with LINK-J
http://inewsletter-king-skyfront.jp/en/news/2018-8-31/

About KING SKYFRONT

The Kawasaki INnovation Gateway (KING) SKYFRONT is the flagship science and technology innovation hub of Kawasaki City. KING SKYFRONT is a 40 hectare area located in the Tonomachi area of the Keihin Industrial Region that spans Tokyo and Kanagawa Prefecture and Tokyo International Airport (also often referred to as Haneda Airport).

KING SKYFRONT was launched in 2013 as a base for scholars, industrialists and government administrators to work together to devise real life solutions to global issues in the life sciences and environment.

Further information

Coastal Area International Strategy Headquarters, Kawasaki City, Japan,
1 Miyamoto-cho, Kawasaki-ku, Kawasaki-city, Kanagawa 210-8577 Japan
EMAIL: 59jigyo@city.kawasaki.jp 
http://www.city.kawasaki.jp/en/category/132-5-0-0-0-0-0-0-0-0.html

Copyright 2019 PR Newswire Association LLC. Back to overview list
to the top ↑